Pediatric Oncology
A section of Cancers (ISSN 2072-6694).
Section Information
Pediatric tumors represent a largely unique and distinct group of tumors as compared to adult cancer, with some overlap in cancer types that occur in adolescents and young adults. In relation to the young patient age, etiology and pathogenesis are frequently completely different from adults, which is reflected in treatment. This patient group is usually treated in tertiary centers, with specialized diagnostic and therapeutic trajectories and increased attention for the long-term physical and psychosocial effects of treatment in survivors. In developing countries, efforts are directed at implementing diagnostic and treatment facilities and preventing treatment abandonment. Thus, the range of topics for the section of Cancers is wide. We encourage the submission of manuscripts which provide new and innovative diagnostic and therapeutic approaches in any medical discipline related to pediatric cancer, including those describing the psychological consequences for patients and their families. Systematic and perspective reviews are also welcome. Topics include, but are not limited to:
- Pediatric cancer surgery
- Innovative surgical techniques
- Imaging modalities in pediatric tumors
- Functional imaging and nuclear scans
- Radiotherapy
- Pediatric tumor pathology
- Molecular diagnostics
- Precision medicine approach to pediatric cancer
- Model systems
- Pediatric cancer trials
- Outcome studies
- Innovative treatment modalities
- Studies on long-term treatment effects, including fertility studies
- Cancer survivor studies
- Psychological and psychosocial consequences
- Studies in adolescents and young adults (AYA)
- Pediatric cancer in developing countries
- Basic research in pediatric cancer
- Tumor heterogeneity
- Drug studies
- Immunotherapy
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Editorial Board Members’ Collection Series: Treatment of Pediatric Solid Tumors (Deadline: 25 November 2023)
- Pediatric/Adolescent Cancer and Exercise (Deadline: 30 November 2023)
- Challenges and New Strategies in the Management of Pediatric Brain Tumors (Deadline: 30 November 2023)
- Rare Tumors in Children: Trends in Diagnosis, Treatment and Prevention (Deadline: 1 December 2023)
- Updates on Management and Clinical Trials in Pediatric Oncology (Deadline: 1 December 2023)
- Molecular Pathology of Pediatric Brain Tumors (Deadline: 15 December 2023)
- New Perspectives on Acute Myeloid Leukemia in Children (Deadline: 31 December 2023)
- Pediatric Cancer: From Molecular Targets to Effective Therapies (Deadline: 19 January 2024)
- Targeted Therapy of Pediatric Cancer (Deadline: 20 February 2024)
- Rare Tumors Involving Bone–Insight into Their Biology, Novel Diagnostic and Therapeutic Tools, including Targeted Therapies (Deadline: 29 February 2024)
- Pathology of Pediatric Cancers (Deadline: 10 March 2024)
- Pediatric Cancer Research from Genetics and Morphology to Experimental Therapy (Deadline: 11 March 2024)
- Pediatric and AYA Sarcoma and Intermediate Tumors (Deadline: 25 March 2024)
- Current Concept and Management of Pediatric ATRTs (Deadline: 30 April 2024)
- Hepatoblastoma and Pediatric Liver Tumors (Volume II) (Deadline: 10 December 2024)
